Key result
Hemoglobin-to-creatinine ratio shows no independent prognostic value for in-hospital mortality in ICU-AMI patients.
Why the study?
Whether the hemoglobin-to-creatinine ratio provides independent prognostic value in critically ill patients with acute myocardial infarction, and whether it offers incremental value beyond the SOFA score, was uncertain.
Does the hemoglobin-to-creatinine (Hb/Cr) ratio provide independent prognostic value and incremental predictive utility beyond the SOFA score for in-hospital mortality in critically ill patients with acute myocardial infarction?
Cohort (n=9,943)
Yes
Does the hemoglobin-to-creatinine (Hb/Cr) ratio provide independent prognostic value and incremental predictive utility beyond the SOFA score for in-hospital mortality in critically ill patients with acute myocardial infarction?
Although the hemoglobin-to-creatinine ratio is associated with in-hospital mortality in basic adjusted models for critically ill AMI patients, its prognostic value is completely encompassed by the 24-hour SOFA score, offering no incremental clinical utility when SOFA is available.
Answers are grounded in this paper and cite their sources.
Hb/Cr ratio should not yet inform mortality risk stratification in ICU-AMI; confirms SOFA captures its prognostic signal in critical care.
Objective: To investigate whether the hemoglobin-to-creatinine (Hb/Cr) ratio provides independent prognostic value in critically ill patients with acute myocardial infarction (AMI), and further, whether it offers incremental value beyond the Sequential Organ Failure Assessment (SOFA) score. Design: Retrospective observational cohort study with external validation. Setting: ICUs from the MIMIC-IV database (2008–2019, discovery) and the eICU-CRD database (2014–2015, multi-center validation). Patients: A total of 6,182 ICU-AMI patients from MIMIC-IV and 3,761 from eICU-CRD (MICE-analyzable cohorts). Interventions: None. Measurements and Main Results: The primary outcome was in-hospital mortality. A three-tier hierarchical strategy was applied: Model 1 (age+sex) replicated prior literature; Model 2 further adjusted for lactate, mechanical ventilation, and cardiogenic shock; Model 3 added SOFA (and renal indicators in MIMIC-IV) to test incremental value. In MIMIC-IV, Hb/Cr was significantly independently associated with mortality in Model 1 (OR = 1.11, p = 0.002) and remained significant in Model 2 (OR = 1.06, p = 0.031), confirming its basic prognostic value. However, after SOFA inclusion in Model 3, the association was completely attenuated to null (OR = 1.003, p = 0.756). This exact pattern was replicated in eICU-CRD (Model 2 OR = 0.945, p < 0.001; Model 3 OR = 0.989, p = 0.148). SOFA-stratified ΔAUCs were <0.005 across all strata (all p > 0.05), and SHAP confirmed SOFA consistently outranked Hb/Cr in feature importance. Conclusions: Hb/Cr does carry independent prognostic information in ICU-AMI patients under traditional/adjusted frameworks. However, this information is entirely encompassed by the SOFA score. In settings where 24-hour SOFA is already available, Hb/Cr offers no additional clinical utility
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2026) conducted a cohort in Critically ill patients with acute myocardial infarction (AMI) (n=9,943). Hemoglobin-to-creatinine (Hb/Cr) ratio vs. Per unit change in Hb/Cr ratio (adjusted for SOFA score in Model 3) was evaluated on In-hospital mortality (fully adjusted Model 3 including SOFA in MIMIC-IV discovery cohort) (OR 1.003, 95% CI 0.982-1.025, p=0.756). The hemoglobin-to-creatinine ratio provided no independent prognostic value for in-hospital mortality in ICU-AMI patients after adjusting for SOFA score.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: